Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Buserelin acetate [USAN:JAN]
RN: 68630-75-1
UNII: 13U86G7YSP
InChIKey: PYMDEDHDQYLBRT-DRIHCAFSSA-N

Note

  • A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications.

Molecular Formula

  • C60-H86-N16-O13.C2-H4-O2

Molecular Weight

  • 1299.49
 

Classification Codes

  • Drug / Therapeutic Agent
  • Gonad-Stimulating Principle
  • Reproductive Effect
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Buserelin acetate [USAN:JAN]

MeSH Heading

  • Buserelin

Synonyms

  • 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide monoacetate (salt)
  • Buserelin acetate
  • HOE 766
  • HOE 766 MP
  • HOE 766MP
  • Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate (salt)
  • Receptal
  • Suprefact
  • UNII-13U86G7YSP

Systematic Name

  • Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate (salt)

Registry Numbers

CAS Registry Number

  • 68630-75-1

FDA UNII

  • 13U86G7YSP

Related Registry Number

  • 57982-77-1 (Parent)

System Generated Number

  • 0068630751

Molecular Formulas

Molecular Formula

  • C60-H86-N16-O13.C2-H4-O2

Molecular Formula Fragments

  • C2-H4-O2
  • C60-H86-N16-O13
  • COMPONENT

Structure Descriptors

InChI

1S/C60H86N16O13.C2H4O2/c1-7-64-57(87)48-15-11-23-76(48)58(88)41(14-10-22-65-59(61)62)69-51(81)42(24-33(2)3)70-56(86)47(31-89-60(4,5)6)75-52(82)43(25-34-16-18-37(78)19-17-34)71-55(85)46(30-77)74-53(83)44(26-35-28-66-39-13-9-8-12-38(35)39)72-54(84)45(27-36-29-63-32-67-36)73-50(80)40-20-21-49(79)68-40;1-2(3)4/h8-9,12-13,16-19,28-29,32-33,40-48,66,77-78H,7,10-11,14-15,20-27,30-31H2,1-6H3,(H,63,67)(H,64,87)(H,68,79)(H,69,81)(H,70,86)(H,71,85)(H,72,84)(H,73,80)(H,74,83)(H,75,82)(H4,61,62,65);1H3,(H,3,4)/t40-,41-,42-,43-,44-,45-,46-,47+,48-;/m0./s1

InChIKey

PYMDEDHDQYLBRT-DRIHCAFSSA-N

Smiles

N1C(CC[C@H]1C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)NCC)CCC1)CCCNC(N)=N)CC(C)C)COC(C)(C)C)=O)Cc1ccc(cc1)O)=O)CO)=O)Cc1c[nH]c2c1cccc2)=O)Cc1cnc[nH]1)=O)=O.CC(=O)O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 subcutaneous > 100mg/kg (100mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: FOOD INTAKE (ANIMAL)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Oyo Yakuri. Pharmacometrics. Vol. 33, Pg. 831, 1987.
mouse LD50 intravenous 56mg/kg (56mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Oyo Yakuri. Pharmacometrics. Vol. 33, Pg. 831, 1987.
mouse LD50 oral > 1gm/kg (1000mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 33, Pg. 831, 1987.
mouse LD50 subcutaneous > 1gm/kg (1000mg/kg) SKIN AND APPENDAGES (SKIN): HAIR: OTHER Oyo Yakuri. Pharmacometrics. Vol. 33, Pg. 831, 1987.
rat LD50 intravenous 36mg/kg (36mg/kg) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: ATAXIA
Oyo Yakuri. Pharmacometrics. Vol. 33, Pg. 831, 1987.
rat LD50 oral > 400mg/kg (400mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 33, Pg. 831, 1987.
rat LD50 subcutaneous > 500mg/kg (500mg/kg) SKIN AND APPENDAGES (SKIN): HAIR: OTHER Oyo Yakuri. Pharmacometrics. Vol. 33, Pg. 831, 1987.